HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hailong An Selected Research

tracheloside

9/2022Multi-target tracheloside and doxorubicin combined treatment of lung adenocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hailong An Research Topics

Disease

18Neoplasms (Cancer)
02/2023 - 01/2014
7Adenocarcinoma of Lung
09/2022 - 01/2019
4Lung Neoplasms (Lung Cancer)
09/2022 - 10/2021
3Asthma (Bronchial Asthma)
01/2022 - 01/2017
3Hypertension (High Blood Pressure)
11/2020 - 01/2017
2Carcinogenesis
07/2022 - 01/2020
2Liver Neoplasms (Liver Cancer)
01/2022 - 01/2020
2Hepatocellular Carcinoma (Hepatoma)
01/2022 - 01/2020
2Body Weight (Weight, Body)
01/2020 - 01/2019
1Hyperalgesia
01/2022
1Bone Resorption
01/2022
1Carcinoma (Carcinomatosis)
01/2022
1Cardiovascular Diseases (Cardiovascular Disease)
01/2022
1Liver Cirrhosis (Hepatic Cirrhosis)
01/2022
1Nervous System Diseases (Neurological Disorders)
01/2022
1Osteoporosis
01/2022
1Chronic Pain
01/2022
1Hypoxia (Hypoxemia)
01/2021
1Weight Loss (Weight Reduction)
01/2021
1Lung Diseases (Lung Disease)
11/2020
1Diarrhea
11/2020
1Neuralgia (Stump Neuralgia)
01/2020
1Epilepsy (Aura)
01/2020
1Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2019
1Neoplasm Metastasis (Metastasis)
01/2019
1Adenocarcinoma
01/2019
1Cystic Fibrosis (Mucoviscidosis)
01/2017
1Intracranial Vasospasm
12/2016
1Channelopathies
01/2014
1Infections
05/2011

Drug/Important Bio-Agent (IBA)

12Pharmaceutical PreparationsIBA
03/2022 - 12/2016
4Chloride Channels (Chloride Channel)IBA
11/2020 - 01/2019
3Proteins (Proteins, Gene)FDA Link
02/2023 - 01/2019
3Annexin A5IBA
07/2022 - 01/2021
3Potassium Channels (Potassium Channel)IBA
01/2022 - 01/2017
2PolymersIBA
07/2022 - 01/2022
2Ion Channels (Ion Channel)IBA
01/2022 - 01/2019
2Biological ProductsIBA
01/2021 - 02/2017
1ZincIBA
02/2023
1ManganeseIBA
02/2023
1Reactive Oxygen Species (Oxygen Radicals)IBA
02/2023
1IonsIBA
02/2023
1Doxorubicin (Adriamycin)FDA LinkGeneric
09/2022
1Drug CombinationsIBA
09/2022
1trachelosideIBA
09/2022
1AnionsIBA
07/2022
1SincalideFDA Link
07/2022
1caffeic acidIBA
07/2022
1CoffeeFDA Link
07/2022
1nuciferineIBA
03/2022
1Cisplatin (Platino)FDA LinkGeneric
03/2022
1glycyl-arginyl-glycyl-aspartyl-serineIBA
01/2022
1zafirlukast (Accolate)FDA LinkGeneric
01/2022
1Anoctamin-1IBA
01/2022
1CollagenIBA
01/2022
1GelsIBA
01/2022
1Peptides (Polypeptides)IBA
01/2022
1Biomarkers (Surrogate Marker)IBA
01/2022
1Protein Disulfide-IsomerasesIBA
01/2022
1HydrogelsIBA
01/2022
1Calcium-Activated Potassium Channels (Calcium-Activated Potassium Channel)IBA
01/2022
1HomoharringtonineIBA
10/2021
1MetalsIBA
01/2021
1theaflavinIBA
01/2021
11-phenyl-3,3-dimethyltriazene (PDT)IBA
01/2021
1Cyclin D1IBA
01/2021
1Silybin (Lagosa)IBA
01/2021
1Oxygen (Dioxygen)IBA
01/2021
1Therapeutic UsesIBA
01/2021
1ezogabine (retigabine)IBA
01/2020
1arctigeninIBA
01/2020
1CalciumIBA
01/2020
1procyanidin B1IBA
01/2020
1tetrandrineIBA
01/2019
1nutlin 3IBA
01/2019
1MatrinesIBA
01/2019
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2017
1InterleukinsIBA
02/2017
1Polysaccharides (Glycans)IBA
02/2017
1fasudil (AT 877)IBA
12/2016
1ChloridesIBA
01/2014
1RNA (Ribonucleic Acid)IBA
05/2011

Therapy/Procedure

9Therapeutics
02/2023 - 01/2017
2Drug Therapy (Chemotherapy)
09/2022 - 01/2020
1Diet Therapy (Therapy, Diet)
07/2022
1Ovariectomy (Oophorectomy)
01/2022
1Photochemotherapy (Photodynamic Therapy)
01/2021